A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma
A Single-Dose, Open-Label, Randomized, 2-Way, Cross-Over Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer From Viatris to Neolpharma, for Spironolactone/Hydrochlorothiazide Film Coated Tablets in Healthy Adult Participants Under Fasted
Conditions
Category & Conditions: Cardiovasular Diseases and Conditions
Medicine: ALDACTAZIDE®(SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE)
ClinicalTrials.gov Identifier (NCT): NCT06205407
Protocol ID: B9531002
Open Plain Language Summary Result:
Click here